Connect with us

COVID-19

Sydney Exits Lockdown as Australia Gears Up to ‘Live with’ COVID

Published

on

Sydney Exits Lockdown as Australia Gears Up to ‘Live with’ COVID

People living in Sydney, Australia’s biggest city, took to the streets on Monday to celebrate the end of almost four months of lockdown as fully vaccinated people were allowed once again to get their hair cut and go to cafes, restaurants, and shops.

The city’s more than five million residents spent 106 days in lockdown as the authorities tried to curb the spread of the highly transmissible delta variant of covid

With new infections now falling, new south wales state recorded 496 cases on Monday, and more than 70 percent of people over the age of 16 fully vaccinated, the city is now reopening and offering services to anyone who can prove they are vaccinated

Watch Our Youtube Videos

Since June, shops, schools, salons, and offices have been closed for non-essential workers and there have been unprecedented restrictions on Australians personal freedom with people banned from travelling more than five kilometers from home or visiting family.

Read Also:

Volcano Destroys 100 Homes in Spain

Messi Scores First Goal as PSG defeats Man City 2-0.

SWAN Selected Camp Opens in Lagos

Continue Reading
Advertisement
Click to comment

Leave a Reply

Your email address will not be published. Required fields are marked *

COVID-19

Moderna to Set Up $500m Vaccine Plant in Africa

Published

on

Moderna to Set Up $500m Vaccine Plant in Africa

Biotechnology company and COVID-19 vaccine maker Moderna says “it will build a state-of-the-art mRNA facility in Africa with the goal of producing up to 500 million doses of vaccines each year.”

In a statement released on Thursday, the company said it anticipates “investing up to $500 million in this new facility which is expected to include drug substance manufacturing with the opportunity for fill/finish and packaging capabilities at the site.”

The process for selecting the country and site is expected to commence soon.
Moderna’s announcement is a victory for voices like the Director-General of the World Trade Organisation, Ngozi Okonjo-Iweala, who have called for vaccine manufacturers to ramp up investment in Africa.

Watch Our Youtube Videos

“Since Moderna’s founding in 2010, our mission has been to make a transformative impact on human lives through our medicines. After a decade of pioneering the development of our mRNA platform, we have been humbled to play a critical role in combatting the COVID-19 pandemic globally with our mRNA vaccine. We view Moderna’s work as only just beginning,” said Stephane Bancel, Moderna’s Chief Executive Officer.

Read Also:

Court Remands Ex-JAMB Registrar, Ojerinde

2-year-old tests positive for Coronavirus in Ogun State

4, 680,000 Nigerians vaccinated – NPHCDA

19 COVID-19 deaths, 281 new infections reported in 12 states, FCT

Continue Reading

COVID-19

J&J seeks US authorisation for its COVID booster shot

Published

on

J&J seeks US authorisation for its COVID booster shot

Drugmaker Johnson & johnson has asked united states regulators for emergency use authorisation of its covid-19 booster shot, the company announced, as the US government moves to expand its booster campaign to millions of vaccinated Americans.

J&j’s filing comes after the FDA last week scheduled an October 15 meeting of its expert advisory committee to discuss whether to authorise a second shot of the company’s single-dose vaccine.

J&j said on Tuesday that it requested the food and drug administration (FDA) authorise boosters for people aged 18 and older who previously received the company’s one-shot vaccine

The drugmaker also said its submission includes data from a late-stage study that found a booster given 56 days after the primary dose provided 94 percent protection against symptomatic covid-19 in the US and 100 percent protection against severe disease, at least 14 days after the booster shot

Watch Our Youtube Videos

While scientists are divided over the need for booster shots when so many people in the US and other countries remain unvaccinated, the administration of president joe Biden announced a push for boosters in august to shore up protection against the highly transmissible delta variant.

Read Also:

U.K Petrol Deliveries: Visas for Foreign Lorry Drivers Extended

Columnist Corner | We Want Bread Not Cake

Continue Reading

COVID-19

J&J Seeks US Authorisation for its COVID Booster Shot

Published

on

J&J Seeks US Authorisation for its COVID Booster Shot

Drugmaker Johnson & Johnson has asked United States regulators for emergency use authorisation of its COVID-19 booster shot, the company announced, as the US government moves to expand its booster campaign to millions of vaccinated Americans.

J&J’s filing comes after the FDA last week scheduled an October 15 meeting of its expert advisory committee to discuss whether to authorise a second shot of the company’s single-dose vaccine.

J&J said on Tuesday that it requested the US Food and Drug Administration (FDA) authorise boosters for people aged 18 and older who previously received the company’s one-shot vaccine.

Watch Our Youtube Videos

The drugmaker also said its submission includes data from a late-stage study that found a booster given 56 days after the primary dose provided 94 percent protection against symptomatic COVID-19 in the US and 100 percent protection against severe disease, at least 14 days after the booster shot.

While scientists are divided over the need for booster shots when so many people in the US and other countries remain unvaccinated, the administration of President Joe Biden announced a push for boosters in August to shore up protection against the highly transmissible Delta variant.

Read Also:

U.K Petrol Deliveries: Visas for Foreign Lorry Drivers Extended

19 COVID-19 deaths, 281 new infections reported in 12 states, FCT

 

Continue Reading

Trending